OSUR
OraSure Technologies, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$3.49
−2.42%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 112.4M | 115.0M | 185.8M | 405.5M | 387.5M |
| Cost of Revenue | 65.9M | 66.8M | 109.6M | 226.1M | 239.0M |
| Gross Profit | 46.5M | 48.2M | 76.2M | 179.4M | 148.4M |
| Operating Expenses | |||||
| R&D Expense | 44.3M | 42.5M | 24.4M | 33.2M | 36.2M |
| SG&A Expense | 77.0M | 73.8M | 72.4M | 92.2M | 117.4M |
| General & Admin Expense | 37.1M | 47.7M | — | — | — |
| Selling & Marketing Expense | 19.5M | 26.1M | — | — | — |
| Other Expenses | (24.4M) | — | — | — | — |
| Total Operating Expenses | 96.8M | 116.3M | 96.8M | 125.3M | 153.7M |
| Cost and Expenses | 162.7M | 183.1M | 206.4M | 351.4M | 392.7M |
| Operating Income (EBIT) | (50.3M) | (68.1M) | (20.6M) | 54.1M | (5.2M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | 1.6M | 1.2M | 2.9M | 2.2M | (10.4M) |
| Non-Operating Income (excl Interest) | 1.2M | (1.2M) | (2.9M) | (2.2M) | 10.4M |
| EBT (Pre-Tax Income) | (48.7M) | (66.9M) | (17.7M) | 56.3M | (15.7M) |
| Income Tax Expense | 393.0K | 1.8M | 1.8M | 2.6M | 1.5M |
| Bottom Line | |||||
| Net Income | (49.1M) | (68.7M) | (19.5M) | 53.7M | (17.1M) |
| Earnings from Cont. Ops | (49.1M) | (68.7M) | (19.5M) | 53.7M | (17.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (49.1M) | (68.7M) | (19.5M) | 53.7M | (17.1M) |
| Per Share | |||||
| Basic EPS | ($0.69) | ($0.94) | ($0.26) | $0.73 | ($0.25) |
| Diluted EPS | ($0.69) | ($0.94) | ($0.26) | $0.72 | ($0.25) |
| Revenue Per Share | $1.63 | $1.57 | $2.50 | $5.53 | $5.34 |
| Shares | |||||
| Basic Shares Outstanding | 69.0M | 73.5M | 74.4M | 73.3M | 72.5M |
| Diluted Shares Outstanding | 70.2M | 73.5M | 74.4M | 74.4M | 72.5M |
| Profitability Metrics | |||||
| EBITDA | (44.1M) | (57.0M) | (6.8M) | 76.2M | (1.7M) |
| D&A | 7.4M | 10.0M | 10.9M | 19.9M | 14.0M |
| EBIT | (51.5M) | (66.9M) | (17.7M) | 56.3M | (15.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026